Gemphire Therapeutics
Northville
About Gemphire Therapeutics
Gemphire Therapeutics manufactures and markets Gemcabene, an LDL cholesterol-lowering medication. It is a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH. The company was founded in 2014 and is based in Northville, Michigan.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $18.4M
- Funding stage: M&A
- Last round: Private Equity (Jan 2020)
- Website: gemphire.com
- Phone: (248) 980-6538
Industries & Categories
Biotechnology, Manufacturing, Therapeutics
Canonical: https://fsome.com/organization/gemphire-therapeutics-182276 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.